Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0001754154-26-000002

CHIEF FINANCIAL OFFICER sold 2,594 shares at $3.31 ($8,585)

  • CHIEF FINANCIAL OFFICER acquired 6,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Giacobello Scott M. CHIEF FINANCIAL OFFICER 2026-03-01 Option exercise +6,750 30,694 D: show line 1 in the form
Giacobello Scott M. CHIEF FINANCIAL OFFICER 2026-03-02 Sale −2,594 $3.31 $8,585 28,100 D: show line 2 in the form
Open-market sales · 2,594 sh · avg $3.31 · $8,585

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Giacobello Scott M. CHIEF FINANCIAL OFFICER 2026-03-01 Option exercise · Restricted Stock Units −6,750 13,500 D: show line 3 in the form
Loading xslF345X05/form4-03102026_110300.xml…